We are a global network of specialists working together to conquer lung and thoracic cancers worldwide.

GAIN: EnGAging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment, and Treatment

Miss a Webinar? Download the one you missed and watch it anytime.

Visit the New IASLC Nurses & Allied Health Professionals Resource Center.

 

 

Abstract Submission deadline for WCLC 2015 - April 15th!

Featured Science and Communiqués

World experts gather for refocusing on patients with small cell lung cancer

Small cell lung cancer (SCLC) will be the concentrated focus when 100 global experts in the field meet for a workshop hosted by the International Association for the Study of Lung Cancer (IASLC) on April 22-24, 2015 at Memorial Sloan Kettering Cancer Center in New York City.

No strong association between lung cancer risk in women and reproductive history or hormone use

The Women’s Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support for a role of hormone use in the incidence of lung cancer.

Physical activity benefits lung cancer patients and survivors.

Exercise and physical activity should be considered as therapeutic options for lung cancer as they have been shown to reduce symptoms, increase exercise tolerance, improve quality of life, and potentially reduce length of hospital stay and complications following surgery for lung cancer.

Early stage NSCLC patients with low tumor metabolic activity have longer survival.

Low pre-surgery uptake of a labeled glucose analogue, a marker of metabolic activity, in the primary tumor of patients with stage I non-small cell lung cancer (NSCLC) is associated with increased overall survival and a longer time before tumor recurrence. Patients with high labeled glucose uptake may benefit from additional therapy following surgery.